• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科急性肺损伤和脓毒症研究人员与儿科血液和骨髓移植联盟联合工作组共识报告:静脉阻塞性疾病患儿和青少年管理的支持性治疗指南,第 1 部分:重点关注检查、预防和具体治疗。

Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 1: Focus on Investigations, Prophylaxis, and Specific Treatment.

机构信息

Division of Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, Ohio.

Division of Pediatric Blood and Marrow Transplantation, The University of Texas, MD Anderson Children's Cancer Hospital, Houston, Texas.

出版信息

Biol Blood Marrow Transplant. 2017 Nov;23(11):1817-1825. doi: 10.1016/j.bbmt.2017.07.021. Epub 2017 Jul 25.

DOI:10.1016/j.bbmt.2017.07.021
PMID:28754544
Abstract

Veno-occlusive disease (VOD) is a common and potentially fatal complication in children undergoing hematopoietic cell transplantation (HCT). It occurs in about one-third of all patients undergoing transplantation and is fatal in 50% of patients with severe disease. Early intervention and specific treatment with defibrotide are associated with improved outcomes. However, there is a lack of supportive care guidelines for management of the multiorgan dysfunction seen in most cases. There is high variability in the management of VOD, which may contribute to the increased morbidity and mortality. Although there is ample research in the specific treatment of VOD, there is paucity of literature regarding the management of ascites, transfusions requirements, fluids and electrolyte dysfunction, delirium, and investigations in children with VOD. The joint working committees of the Pediatric Acute Lung Injury and Sepsis Investigators and the Pediatric Blood and Marrow Transplantation Consortium collaborated to develop a series of evidence-based supportive care guidelines for management of VOD. The quality of evidence was rated and recommendations were made using Grading of Recommendations, Assessment, Development and Evaluation criteria. This manuscript is part 1 of the series and focuses on the need to develop these guidelines; methodology used to establish the guidelines; and investigations needed for diagnosis, prophylaxis, and treatment of VOD in children.

摘要

静脉闭塞病(VOD)是进行造血细胞移植(HCT)的儿童中常见且潜在致命的并发症。它发生在所有接受移植的患者中的约三分之一,并且在 50%的严重疾病患者中是致命的。早期干预和使用去纤维蛋白治疗与改善结果相关。然而,对于大多数情况下出现的多器官功能障碍的管理,缺乏支持性护理指南。VOD 的管理存在高度的可变性,这可能导致发病率和死亡率增加。尽管在 VOD 的特定治疗方面有大量研究,但关于腹水、输血需求、液体和电解质功能障碍、谵妄以及 VOD 儿童的检查的管理方面文献很少。儿科急性肺损伤和脓毒症调查员以及儿科血液和骨髓移植联合会的联合工作组合作制定了一系列基于证据的支持性护理指南,用于管理 VOD。对证据质量进行了评级,并使用推荐评估、制定与评价标准(Grading of Recommendations, Assessment, Development and Evaluation)提出了建议。本文是该系列的第 1 部分,重点介绍了制定这些指南的必要性;用于制定指南的方法;以及用于诊断、预防和治疗儿童 VOD 的检查。

相似文献

1
Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 1: Focus on Investigations, Prophylaxis, and Specific Treatment.儿科急性肺损伤和脓毒症研究人员与儿科血液和骨髓移植联盟联合工作组共识报告:静脉阻塞性疾病患儿和青少年管理的支持性治疗指南,第 1 部分:重点关注检查、预防和具体治疗。
Biol Blood Marrow Transplant. 2017 Nov;23(11):1817-1825. doi: 10.1016/j.bbmt.2017.07.021. Epub 2017 Jul 25.
2
Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplant Consortium Joint Working Committees on Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents: Part 2-Focus on Ascites, Fluid and Electrolytes, Renal, and Transfusion Issues.儿科急性肺损伤和脓毒症研究人员以及儿科血液和骨髓移植联合会关于支持性护理指南的共识报告:管理儿童和青少年静脉阻塞性疾病的第 2 部分 - 重点关注腹水、液体和电解质、肾脏和输血问题。
Biol Blood Marrow Transplant. 2017 Dec;23(12):2023-2033. doi: 10.1016/j.bbmt.2017.08.014. Epub 2017 Aug 17.
3
BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.BCSH/BSBMT 指南:造血干细胞移植后静脉闭塞病(窦状隙阻塞综合征)的诊断和治疗。
Br J Haematol. 2013 Nov;163(4):444-57. doi: 10.1111/bjh.12558. Epub 2013 Sep 17.
4
Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees on Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 3: Focus on Cardiorespiratory Dysfunction, Infections, Liver Dysfunction, and Delirium.儿童急性肺损伤和脓毒症研究组与儿科血液和骨髓移植联盟支持性护理指南工作组的共识报告:静脉闭塞性疾病管理指南,第 3 部分:关注心肺功能障碍、感染、肝功能障碍和谵妄。
Biol Blood Marrow Transplant. 2018 Feb;24(2):207-218. doi: 10.1016/j.bbmt.2017.08.035. Epub 2017 Sep 1.
5
High Variability in the Reported Management of Hepatic Veno-Occlusive Disease in Children after Hematopoietic Stem Cell Transplantation.造血干细胞移植后儿童肝静脉闭塞病报告管理的高度变异性。
Biol Blood Marrow Transplant. 2016 Oct;22(10):1823-1828. doi: 10.1016/j.bbmt.2016.07.011. Epub 2016 Aug 2.
6
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.去纤苷治疗肝静脉闭塞病/窦性阻塞综合征患者:一项治疗性 IND 研究的中期结果。
Biol Blood Marrow Transplant. 2017 Jun;23(6):997-1004. doi: 10.1016/j.bbmt.2017.03.008. Epub 2017 Mar 8.
7
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program.去纤苷治疗肝静脉闭塞病:国际同情用药项目的最终结果
Biol Blood Marrow Transplant. 2016 Oct;22(10):1874-1882. doi: 10.1016/j.bbmt.2016.07.001. Epub 2016 Jul 7.
8
Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management.造血干细胞移植后静脉闭塞性疾病/窦性阻塞综合征:中东/北非地区预防、诊断和管理共识
Bone Marrow Transplant. 2017 Apr;52(4):588-591. doi: 10.1038/bmt.2016.300. Epub 2016 Nov 28.
9
Low, fixed dose defibrotide in management of hepatic veno-occlusive disease post stem cell transplantation.
Hematol Oncol Stem Cell Ther. 2018 Mar;11(1):47-51. doi: 10.1016/j.hemonc.2017.02.005. Epub 2017 Apr 25.
10
A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.造血干细胞移植后儿童肝静脉闭塞病发病率、危险因素及治疗的前瞻性研究。
Haematologica. 2005 Oct;90(10):1396-404.

引用本文的文献

1
Massive Bleeding in Children With Cancer or Hematopoietic Cell Transplant: International, Multicenter Retrospective Study, 2017-2021.癌症或造血细胞移植患儿的大出血:2017 - 2021年国际多中心回顾性研究
Pediatr Crit Care Med. 2025 Jul 1;26(7):e889-e899. doi: 10.1097/PCC.0000000000003751. Epub 2025 Apr 25.
2
Incidence, risk factors, and outcomes of transplant-associated thrombotic microangiopathy in pediatric patients after allogeneic hematopoietic cell transplantation: a single-institution prospective study.异基因造血细胞移植后儿童患者移植相关血栓性微血管病的发病率、危险因素及预后:一项单中心前瞻性研究
Bone Marrow Transplant. 2025 Apr;60(4):447-457. doi: 10.1038/s41409-024-02506-w. Epub 2025 Jan 15.
3
Biomarker-derived fast-and-frugal decision tree for preemption of veno-occlusive disease/sinusoidal obstructive syndrome.
基于生物标志物的快速节俭决策树用于预测静脉闭塞性疾病/窦性阻塞综合征
Blood Adv. 2024 Oct 22;8(20):5426-5429. doi: 10.1182/bloodadvances.2024013670.
4
Retrospective analysis of veno-occlusive disease/sinusoidal obstruction syndrome in paediatric patients undergoing hematopoietic cell transplantation -a multicentre study.造血干细胞移植患儿静脉闭塞性疾病/窦性阻塞综合征的回顾性分析——一项多中心研究
Lancet Reg Health Am. 2024 Apr 6;33:100728. doi: 10.1016/j.lana.2024.100728. eCollection 2024 May.
5
Hepatic veno-occlusive disease complicated with extreme hyperammonaemia (920 µmol/L) treated with defibrotide, lactulose, rifampin and haemodialysis.肝静脉闭塞病伴极重度高血氨(920µmol/L),用多黏菌素 B 脂质体、乳果糖、利福平和血液透析治疗。
BMJ Case Rep. 2024 Mar 21;17(3):e258876. doi: 10.1136/bcr-2023-258876.
6
Incidence, management and outcome of Hepatic Veno-Occlusive disease /Sinusoidal Obstruction Syndrome after hematopoietic stem cell transplant in Thalassemia major patients: A prospective study of Pakistani BMT.重型地中海贫血患者造血干细胞移植后肝静脉闭塞病/窦性阻塞综合征的发病率、管理及结局:巴基斯坦骨髓移植的一项前瞻性研究
Pak J Med Sci. 2024 Jan-Feb;40(3Part-II):259-264. doi: 10.12669/pjms.40.3.7901.
7
Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation.造血细胞移植后窦状隙阻塞综合征风险生物标志物的前瞻性评估。
JCI Insight. 2023 May 22;8(10):e168221. doi: 10.1172/jci.insight.168221.
8
Epidemiology, antimicrobial resistance, and mortality risk factors of carbapenem resistant gram-negative bacteria in hematopoietic stem cell transplantation recipients.造血干细胞移植受者中碳青霉烯类耐药革兰氏阴性菌的流行病学、抗菌药物耐药性和死亡危险因素。
Front Cell Infect Microbiol. 2023 Jan 13;12:1098856. doi: 10.3389/fcimb.2022.1098856. eCollection 2022.
9
Interest of the preventive and curative use of defibrotide on the occurrence and severity of sinusoidal obstruction syndrome after hematopoietic stem cell transplant in children.去纤苷预防和治疗儿童造血干细胞移植后窦性阻塞综合征的发生及严重程度的研究意义。
EJHaem. 2022 May 31;3(3):885-893. doi: 10.1002/jha2.480. eCollection 2022 Aug.
10
Up-regulation of TUG1 can regulate miR-494/PDK4 axis to inhibit LPS-induced acute lung injury caused by sepsis.TUG1的上调可调节miR-494/PDK4轴,以抑制脓毒症引起的脂多糖诱导的急性肺损伤。
Am J Transl Res. 2021 Nov 15;13(11):12375-12385. eCollection 2021.